Clinical Trials Directory

Trials / Unknown

UnknownNCT05836441

Improved Phototherapy in Patients With Vitiligo

A Multicenter, Randomized, Open, Parallel Controlled Clinical Study Evaluating the Efficacy and Safety of Improved Phototherapy in Patients With Vitiligo

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

Vitiligo is a common acquired depigmentation skin and mucosal disease in dermatology, with or without white hair. Vitiligo with white hair is difficult to treat. Phototherapy and topical therapy are the first line treatment methods for vitiligo. The peripheral leukoplakia irradiation of phototherapy covers the central area of the leukoplakia and performs phototherapy on the edge of the leukoplakia and surrounding normal skin. This study aims to compare the efficacy and safety of peripheral leukoplakia ultraviolet family phototherapy and leukoplakia family combination in the treatment of vitiligo.

Conditions

Interventions

TypeNameDescription
RADIATIONExposure to white patchesExposure to white patches
RADIATIONExposure to edge of white patches and normal skin around white patchesExposure to edge of white patches and normal skin around white patches

Timeline

Start date
2022-01-01
Primary completion
2023-07-30
Completion
2023-12-30
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05836441. Inclusion in this directory is not an endorsement.